Ion-channel assay technologies: quo vadis?
- 3 December 2001
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 6 (24), 1278-1287
- https://doi.org/10.1016/s1359-6446(01)02095-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Drug discovery technology for ion channelsDrug Discovery Today, 2001
- Screening lead compounds for QT interval prolongationDrug Discovery Today, 2001
- Voltage-gated sodium channels as therapeutic targetsDrug Discovery Today, 2000
- QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience.European Journal of Clinical Pharmacology, 2000
- Cell-based assays and instrumentation for screening ion-channel targetsDrug Discovery Today, 1999
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- HTS approaches to voltage-gated ion channel drug discoveryDrug Discovery Today, 1998
- Human Ether-a-gogo Related Gene (HERG) K Channels as Pharmacological TargetsBiochemical Pharmacology, 1998
- A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channelCell, 1995
- A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndromeCell, 1995